The Optical Society Commends Congress and President Obama on the 21st Century Cures Act

13 December 2016

The Optical Society Commends Congress and President Obama
on the 21st Century Cures Act

WASHINGTON —The Optical Society (OSA) issued the following statement applauding the 21st Century Cures Act, which provides $6.3 billion in funding for advanced medical research and health care initiatives, including $4.8 billion for photonics-enabled areas of medicine, such as the Cancer Moonshot, the Precision Medicine Initiative and the BRAIN Initiative. The Act also includes provisions to reduce administrative burdens on researchers. Please attribute to Elizabeth Rogan, CEO of The Optical Society. 
“The 21st Century Cares Act provides critical research funding to advance health care innovation, including imaging technologies that are enabled by optics and photonics.”

“These innovations will further enable noninvasive optical imaging technologies; providing clearer insight into diseases such as Alzheimer’s and epilepsy. Along with improved imaging techniques, advances in laser surgical equipment and precision biomedical devices have made cancer diagnosis and treatment more effective, which are key to achieving the goals set by the US Vice President’s Cancer Moonshot Task Force.”

“We applaud the bi-partisan support in Congress to strengthen health care research. The Optical Society, working with the National Photonics Initiative, endorses this R&D funding initiative.”

About The Optical Society
Founded in 1916, The Optical Society (OSA) is the leading professional organization for scientists, engineers, students and business leaders who fuel discoveries, shape real-life applications and accelerate achievements in the science of light. Through world-renowned publications, meetings and membership initiatives, OSA provides quality research, inspired interactions and dedicated resources for its extensive global network of optics and photonics experts. The Optical Society is a founding sponsor of the National Photonics Initiative. For more information, visit

Media Contacts: